Newsmeme!
Discover News you didn't know existed
Adjuvant Treatment
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Cedars Sinai Researchers Present New Findings At Neuroscience Meetings
Published November 20, 2008, 3:10 am, Medical News Today
Researchers from Cedars-Sinai Medical Center are presenting findings during the 38th annual meeting of the Society for Neuroscience. Neuroscience 2008 is at the Walter E. Washington Convention Center in Washington, D.C., Nov. 15 through 19, and is expected to draw more than 30,000 attendees from around the world.
CHMP recommends IDM Pharma's mifamurtide for bone tumour
Published November 20, 2008, 1:49 am, PharmaBiz
IDM Pharma, Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion, recommending grant of a centralized marketing authorization for mifamurtide (L-MTP-PE), known as Mepact in Europe, for the treatment of patients with non-metastatic, resectable osteosarcoma, a rare and often fatal bone tumour that ...
Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at ...
Published November 19, 2008, 8:00 am, CNW Group via Yahoo! Finance
Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced today that it will be presenting an abstract on the Phase II data from Neuradiab at the Society for Neuro-Oncology's 13th Annual Scientific Meeting.
Cedars-Sinai researchers present new findings at neuroscience meetings
Published November 19, 2008, 7:31 am, EurekAlert!
( Cedars-Sinai Medical Center ) Researchers from Cedars-Sinai Medical Center are presenting recent findings during the 38th annual meeting of the Society for Neuroscience. Neuroscience 2008 is being held at the Walter E. Washington Convention Center in Washington, D.C., through Nov. 19, and is expected to draw more than 30,000 attendees from around the world.
Cedars-Sinai Researchers Present New Findings at Neuroscience Meetings
Published November 19, 2008, 7:25 am, Newswise
Researchers from Cedars-Sinai Medical Center are presenting recent findings during the 38th annual meeting of the Society for Neuroscience. Neuroscience 2008 is being held at the Walter E. Washington Convention Center in Washington, D.C., Nov. 15 through 19, and is expected to draw more than 30,000 attendees from around the world.
Sanofi-Aventis Pharma S.A. Withdraws Its Application For An Extension Ofindication For Taxotere And Docetaxel Winthrop ...
Published November 18, 2008, 5:08 am, Medical News Today
The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis Pharma S.A. of its decision to withdraw its application for an extension of indication for the centrally authorised medicines Taxotere (docetaxel) 20 mg/0.5 ml and 80 mg/2 ml, concentrate and solvent for solution for infusion and Docetaxel Winthrop (docetaxel) 20 mg/0.
IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients ...
Published November 18, 2008, 4:30 am, PR Newswire via Yahoo! Finance
IDM Pharma, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion, recommending grant of a centralized marketing authorization for mifamurtide , known as MEPACT® in Europe, for the treatment of patients with non-metastatic, resectable osteosarcoma, a rare and often fatal bone tumor that typically affects ...
Vitamin E
Published November 18, 2008, 3:34 am, ThirdAge
Vitamin E is an antioxidant that fights damaging natural substances known as free radicals. It works in lipids (fats and oils), which makes it complementary to vitamin C, which fights free radicals dissolved in water.
New Patient Study Suggests Siemens Non-Invasive Blood Test May Have a Role in Monitoring Breast Cancer Patients' ...
Published November 17, 2008, 8:36 am, PR Newswire via Yahoo! Finance
Siemens Healthcare announced that data from a new study published in the American Cancer Society journal Cancer, supports using the Siemens Serum HER-2/neu test to monitor patients with an aggressive type of metastatic breast cancer.
BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon
Published November 17, 2008, 5:00 am, Business Wire via Yahoo! Finance
LINCOLNSHIRE, Ill.----BioSante Pharmaceuticals, Inc. announced today that the company has been awarded a $150,000 Small Business Innovation Research grant from the National Institutes of Health to support the company's development of formulations for the pulmonary delivery of interferon alpha using its proprietary calcium phosphate nanoparticulate technology.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |